Impact of a Student-Supported Pharmacy Assessment Program on Venous Thromboembolism Prophylaxis Rates in Hospitalized Patients

被引:4
作者
Butkievich, Laura E. [1 ]
Stacy, Zachary A. [1 ,2 ]
Daly, Michael W. [1 ,2 ]
Huey, Way Y. [1 ]
Taylor, Charles T. [3 ]
机构
[1] St Lukes Hosp, Chesterfield, MO USA
[2] St Louis Coll Pharm, St Louis, MO USA
[3] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
关键词
pharmacy student; advanced pharmacy practice experience; venous thromboembolism; ILL MEDICAL PATIENTS; CLINICAL INTERVENTIONS; PREVENTION; PLACEBO; CARE;
D O I
10.5688/aj7406105
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objectives. To determine if the addition of a student-supported venous thromboembolism risk assessment strategy could improve rates of venous thromboembolism prophylaxis at a community teaching hospital. Methods. After receiving education and training on venous thromboembolism risk assessment, students assessed patients and recommended therapy in a 493-bed community teaching hospital over 5 weeks. Both the quantity and quality of venous thromboembolism prophylaxis were measured and compared to a baseline rate. Results. One hundred three recommendations were made to physicians with a 41% acceptance rate. Compared to previous rates, the percentages of patients receiving "any,'' "suitable,'' and "optimal'' venous thromboembolism prophylaxis increased from 70.5% to 82.7% (p = 0.0005), 64.4% to 75.9% (p = 0.0022), and 56.3% to 68.5% (p = 0.0022), respectively. Conclusions. A student-supported venous thromboembolism risk assessment strategy resulted in an increase in venous thromboembolism prophylaxis rates and could be used as a model for other institutions to integrate students into population-based care.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 15 条
[1]  
[Anonymous], ACCR STAND GUID PROF
[2]   A computerized reminder system to increase the use of preventive care for hospitalized patients. [J].
Dexter, PR ;
Perkins, S ;
Overhage, JM ;
Maharry, K ;
Kohler, RB ;
McDonald, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :965-970
[3]  
Dobesh Paul P, 2005, J Manag Care Pharm, V11, P755
[4]  
Enders JM, 2002, PHARMACOTHERAPY, V22, P1344
[5]  
FANIKOS J, PHARM ESSENTIALS PRE
[6]   Prophylaxis for thromboembolism in hospitalized medical patients [J].
Francis, Charles W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (14) :1438-1444
[7]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[8]  
*ICSI, 2007, VEN THROMB PROPH
[9]   Electronic alerts to prevent venous thromboembolism among hospitalized patients [J].
Kucher, N ;
Koo, S ;
Quiroz, R ;
Cooper, JM ;
Paterno, MD ;
Soukonnikov, B ;
Goldhaber, SZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :969-977
[10]   Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients [J].
Leizorovicz, A ;
Cohen, AT ;
Turpie, AGG ;
Olsson, CG ;
Vaitkus, PT ;
Goldhaber, SZ .
CIRCULATION, 2004, 110 (07) :874-879